GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (NYSE:NGVT) » Definitions » Beneish M-Score
中文

Ingevity (Ingevity) Beneish M-Score : -2.57 (As of Apr. 24, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ingevity Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ingevity's Beneish M-Score or its related term are showing as below:

NGVT' s Beneish M-Score Range Over the Past 10 Years
Min: -2.92   Med: -2.49   Max: -1.91
Current: -2.57

During the past 12 years, the highest Beneish M-Score of Ingevity was -1.91. The lowest was -2.92. And the median was -2.49.


Ingevity Beneish M-Score Historical Data

The historical data trend for Ingevity's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity Beneish M-Score Chart

Ingevity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.21 -2.87 -2.49 -2.28 -2.57

Ingevity Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.28 -2.41 -2.35 -2.65 -2.57

Competitive Comparison of Ingevity's Beneish M-Score

For the Specialty Chemicals subindustry, Ingevity's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ingevity's Beneish M-Score Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ingevity's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ingevity's Beneish M-Score falls into.



Ingevity Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ingevity for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8345+0.528 * 1.2253+0.404 * 0.9886+0.892 * 1.0143+0.115 * 0.8751
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.911+4.679 * -0.011817-0.327 * 1.0302
=-2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $211 Mil.
Revenue was 371.7 + 446 + 481.8 + 392.6 = $1,692 Mil.
Gross Profit was 59.5 + 129 + 153 + 130.4 = $472 Mil.
Total Current Assets was $659 Mil.
Total Assets was $2,623 Mil.
Property, Plant and Equipment(Net PPE) was $829 Mil.
Depreciation, Depletion and Amortization(DDA) was $123 Mil.
Selling, General, & Admin. Expense(SGA) was $184 Mil.
Total Current Liabilities was $363 Mil.
Long-Term Debt & Capital Lease Obligation was $1,431 Mil.
Net Income was -116.8 + 25.2 + 35.5 + 50.7 = $-5 Mil.
Non Operating Income was -140.2 + -26 + -24 + 10.7 = $-180 Mil.
Cash Flow from Operations was 44.6 + 106.9 + 48.4 + 5.2 = $205 Mil.
Total Receivables was $249 Mil.
Revenue was 383.6 + 482 + 419.9 + 382.8 = $1,668 Mil.
Gross Profit was 105.4 + 176.3 + 150.6 + 137.8 = $570 Mil.
Total Current Assets was $683 Mil.
Total Assets was $2,737 Mil.
Property, Plant and Equipment(Net PPE) was $855 Mil.
Depreciation, Depletion and Amortization(DDA) was $109 Mil.
Selling, General, & Admin. Expense(SGA) was $199 Mil.
Total Current Liabilities was $304 Mil.
Long-Term Debt & Capital Lease Obligation was $1,513 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(211 / 1692.1) / (249.3 / 1668.3)
=0.124697 / 0.149434
=0.8345

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(570.1 / 1668.3) / (471.9 / 1692.1)
=0.341725 / 0.278884
=1.2253

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (658.6 + 829.3) / 2623.3) / (1 - (683.3 + 855.2) / 2736.5)
=0.432814 / 0.437785
=0.9886

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1692.1 / 1668.3
=1.0143

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(108.8 / (108.8 + 855.2)) / (122.8 / (122.8 + 829.3))
=0.112863 / 0.128978
=0.8751

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(183.7 / 1692.1) / (198.8 / 1668.3)
=0.108563 / 0.119163
=0.911

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1431.4 + 362.9) / 2623.3) / ((1513.3 + 303.5) / 2736.5)
=0.683986 / 0.663914
=1.0302

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-5.4 - -179.5 - 205.1) / 2623.3
=-0.011817

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ingevity has a M-score of -2.57 suggests that the company is unlikely to be a manipulator.


Ingevity Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Ingevity's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Ingevity (Ingevity) Business Description

Traded in Other Exchanges
Address
4920 O'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America.
Executives
Christine Stunyo officer: SVP, Chief HR Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
White Richard Allen Jr officer: SVP, Perf Chem and Pres, ISPT 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405
Phillip John Platt officer: VP, CAO & Corporate Controller 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Woodcock Stuart Edward Jr. officer: EVP, President Perf Materials 5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Bruce D. Hoechner director 2225 W CHANDLER BLVD, CHANDLER AZ 85224
Erik Spencer Ripple officer: Chief Growth & Innov Officer 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
Benjamin G. Wright director 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
William J Slocum director C/O INCLUSIVE CAPITAL PARTNERS, L.P., 1170 GORGAS AVENUE, SAN FRANCISCO CA 94129
J Michael Fitzpatrick director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612-4662
Diane H. Gulyas director C/O EXPEDITORS, 1015 THIRD AVENUE, SEATTLE WA 98104
Jean S Blackwell director
Frederick J Lynch director C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Luis M Fernandez-moreno director ASHLAND INC., 8145 BLAZER DRIVE, WILMINGTON DE 19808
Karen G Narwold director ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Steven Paul Hulme officer: SVP, Perf Chem and Pres, EP 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405